How is the Catalyst Pharmaceuticals Inc today?

The Catalyst Pharmaceuticals Inc today is trading in the green, up by 1.53% at 25.29.

How has Catalyst Pharmaceuticals Inc performed historically?

The Catalyst Pharmaceuticals Inc is currently trading up 1.53% on an intraday basis in the past week the index rose 1.81%. The index has been up 13.31% in the past quarter and rose 56.30% in the past year. You can view this in the overview section.

What is Catalyst Pharmaceuticals Inc Annual Revenue?

Catalyst Pharmaceuticals Inc Annual Revenue rose 23.49%, in the last year to $491.73 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Catalyst Pharmaceuticals Inc Annual Net Profit?

Catalyst Pharmaceuticals Inc Annual Net Profit rose 129.5% in the last year to $163.89 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Catalyst Pharmaceuticals Inc Price to Earning Ratio?

Catalyst Pharmaceuticals Inc Price to Earning Ratio is 15.63, higher than its sector PE ratio of 4.55.

What is Catalyst Pharmaceuticals Inc Stock Price?

Catalyst Pharmaceuticals Inc Stock Price rose 56.3% and outperformed its sector by 27.86% in the past year.

What is Catalyst Pharmaceuticals Inc Quarterly Revenue?

Catalyst Pharmaceuticals Inc Quarterly Revenue rose 43.56% YoY to $141.42 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Catalyst Pharmaceuticals Inc Quarterly Net profit?

Catalyst Pharmaceuticals Inc Quarterly Net profit rose 143.77% YoY to $56.74 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Catalyst Pharmaceuticals Inc Debt to Equity Ratio?

Catalyst Pharmaceuticals Inc Debt to Equity Ratio is zero as the company is debt-free.

What is Catalyst Pharmaceuticals Inc Return on Equity(ROE)?

Catalyst Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was 29.38%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is Catalyst Pharmaceuticals Inc Mutual Fund Holding?

Catalyst Pharmaceuticals Inc Mutual Fund Holding decreased by 1.28% in the last quarter to 58.15.

What is Catalyst Pharmaceuticals Inc Promoter Share Holding?

Catalyst Pharmaceuticals Inc Promoter Share Holding decreased by 0.03% in the most recent quarter to 6.66%.

What is Catalyst Pharmaceuticals Inc Institutional Holding?

Catalyst Pharmaceuticals Inc Institutional Holding increased by 3.43% in the last quarter to 83.53.

Catalyst Pharmaceuticals Inc XNAS: CPRX

Catalyst Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Catalyst Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Catalyst Pharmaceuticals Inc
Rating: 3.175472125
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAP...

25.29 0.38 (1.53%)

Near 52W High of $26.16

1.1M XNAS Volume

XNAS 04 Jun, 2025 5:30 PM (EDT)

High Financial Strength

72.2 / 100

Mid Valuation

44.3 / 100

Technically Moderately Bullish

65.3 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM

1Yr Price target upside is 34%

8 analysts

Catalyst Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Catalyst Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAP...

Near 52W High of $26.16

SWOT Analysis

Catalyst Pharmaceuticals Inc Live Price Chart

Catalyst Pharmaceuticals Inc FAQ

How is Catalyst Pharmaceuticals Inc today?

Catalyst Pharmaceuticals Inc today is trading in the green, and is up by 1.53% at 25.29.

How has Catalyst Pharmaceuticals Inc performed historically?

Catalyst Pharmaceuticals Inc is currently trading up 1.53% on an intraday basis. In the past week the stock rose 1.81%. stock has been up 13.31% in the past quarter and rose 56.30% in the past year. You can view this in the overview section.